Perfect Medical Health Management Limited (1830.HK)
Mong Kok, HK
Operating as an investment holding firm, Perfect Medical Health Management Limited delivers a comprehensive suite of medical and aesthetic services across Hong Kong, mainland China, Macau, Singapore, and Australia. Its offerings encompass medical aesthetics, hair restoration, pain relief, proactive health management, and fertility treatments. Beyond its core medical provisions, the company is involved in advertising, charitable initiatives, and management services, while also holding trademarks, leasing equipment, and operating a network of service centers. Established in 2003, the company, initially known as Perfect Shape Medical Limited, adopted its current name, Perfect Medical Health Management Limited, in June 2021. Its corporate headquarters are located in Mong Kok, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.54% | -4.17% | -4.17% | -4.96% | -17.86% | -7.26% | -51.06% | -66.18% | -85.89% | +45.57% | +29.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-10 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%-14.7% Q1'26: -29.4% (vs Q1'24)
-
EPS growth Personal Products & Services: +19.6%-12.5% Q1'26: -44.3% (vs Q1'24)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+34.2% Q1'26: +32.8% (vs Q1'24)
-
EBIT margin Personal Products & Services: +10.5%+22.5% ★ Q1'26: +22.2% (vs Q1'24)
-
ROIC Personal Products & Services: +6.9%+80.9% ★ Q1'26: +162.7% (vs Q1'24)
-
Share dilution Personal Products & Services: +0.0%+0.0% Q1'26: +0.0% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×0.36× ★ Q1'26: 0.19× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
470.24M
est: 511.56M (-8.1%)
|
728.66M
est: 660.50M (+10.3%)
|
879.12M
est: 997.00M (-11.8%)
|
756.98M
est: 660.50M (+14.6%)
|
906.28M
est: 997.00M (-9.1%)
|
1.20B
est: 752.90M (+59.0%)
|
1.24B
est: 797.60M (+55.6%)
|
1.09B
est: 851.20M (+28.0%)
|
1.35B
est: 1.30B (+3.8%)
|
1.39B
est: 1.43B (-2.5%)
|
1.39B
est: 1.41B (-1.0%)
|
1.13B
est: 1.28B (-11.5%)
|
1.13B
1.13B – 1.13B
-11.6% YoY
|
1.22B
1.22B – 1.22B
+8.2% YoY
|
1.31B
1.31B – 1.31B
+7.4% YoY
|
| EBITDA |
127.04M
est: 217.75M (-41.7%)
|
216.83M
est: 281.15M (-22.9%)
|
241.22M
est: 424.39M (-43.2%)
|
203.67M
est: 281.15M (-27.6%)
|
316.20M
est: 255.25M (+23.9%)
|
466.26M
est: 320.48M (+45.5%)
|
617.30M
est: 339.51M (+81.8%)
|
474.13M
est: 362.32M (+30.9%)
|
602.84M
est: 553.36M (+8.9%)
|
592.40M
est: 606.78M (-2.4%)
|
596.91M
est: 598.91M (-0.3%)
|
441.97M
est: 542.72M (-18.6%)
|
479.72M
479.72M – 479.72M
-11.6% YoY
|
518.88M
518.88M – 518.88M
+8.2% YoY
|
557.19M
557.19M – 557.19M
+7.4% YoY
|
| EBIT |
114.43M
est: 137.60M (-16.8%)
|
170.30M
est: 177.66M (-4.1%)
|
161.11M
est: 268.17M (-39.9%)
|
117.49M
est: 177.66M (-33.9%)
|
236.20M
est: 137.07M (+72.3%)
|
395.87M
est: 307.77M (+28.6%)
|
462.48M
est: 214.54M (+115.6%)
|
302.87M
est: 228.95M (+32.3%)
|
383.79M
est: 349.67M (+9.8%)
|
368.81M
est: 383.43M (-3.8%)
|
394.95M
est: 378.45M (+4.4%)
|
263.63M
est: 342.95M (-23.1%)
|
303.14M
303.14M – 303.14M
-11.6% YoY
|
327.88M
327.88M – 327.88M
+8.2% YoY
|
352.09M
352.09M – 352.09M
+7.4% YoY
|
| Net Income |
83.02M
est: 115.32M (-28.0%)
|
134.91M
est: 154.02M (-12.4%)
|
130.02M
est: 189.57M (-31.4%)
|
91.36M
est: 154.02M (-40.7%)
|
194.19M
est: 111.93M (+73.5%)
|
319.03M
est: 237.92M (+34.1%)
|
360.16M
est: 94.79M (+280.0%)
|
284.63M
est: 106.63M (+166.9%)
|
305.25M
est: 288.93M (+5.6%)
|
315.64M
est: 251.24M (+25.6%)
|
315.80M
est: 315.80M (+0.0%)
|
206.90M
est: 326.61M (-36.7%)
|
251.24M
251.24M – 251.24M
-23.1% YoY
|
288.93M
288.93M – 288.93M
+15.0% YoY
|
326.61M
326.61M – 326.61M
+13.0% YoY
|
| SGA |
124.64M
est: 74.94M (+66.3%)
|
120.23M
est: 96.75M (+24.3%)
|
172.63M
est: 146.05M (+18.2%)
|
124.41M
est: 96.75M (+28.6%)
|
133.50M
est: 633.89M (-78.9%)
|
229.35M
est: 677.76M (-66.2%)
|
199.27M
est: 116.84M (+70.5%)
|
207.88M
est: 124.69M (+66.7%)
|
194.98M
est: 190.43M (+2.4%)
|
178.24M
est: 208.82M (-14.6%)
|
182.74M
est: 206.11M (-11.3%)
|
155.41M
est: 186.77M (-16.8%)
|
165.09M
165.09M – 165.09M
-11.6% YoY
|
178.57M
178.57M – 178.57M
+8.2% YoY
|
191.75M
191.75M – 191.75M
+7.4% YoY
|
| EPS |
0.08
est: 0.09 (-9.6%)
|
0.12
est: 0.12 (-2.1%)
|
0.12
est: 0.15 (-20.5%)
|
0.08
est: 0.12 (-33.3%)
|
0.18
est: 0.15 (+19.3%)
|
0.29
est: 0.07 (+339.2%)
|
0.32
est: 0.08 (+324.1%)
|
0.24
est: 0.08 (+182.7%)
|
0.25
est: 0.23 (+8.7%)
|
0.25
est: 0.20 (+25.0%)
|
0.25
est: 0.26 (-3.8%)
|
0.16
est: 0.26 (-38.5%)
|
0.20
0.20 – 0.20
-23.1% YoY
|
0.23
0.23 – 0.23
+15.0% YoY
|
0.26
0.26 – 0.26
+13.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 71.6K | 0.22% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 44.8K | 0.28% |
| 3 | Avantis International Equity ETF AVDE | 0.00% | 15.9K | 0.23% |
| 4 | Avantis Responsible International Equity ETF AVSD | 0.00% | 176.44 | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kong Au-Yeung | Founder, Executive Chairman & Chief Executive Officer | 31M | — |
| Hung Au-Yeung | Executive Director | 5M | female |
| Wai Au-Yeung | Chief Operating Officer & Executive Director | 5M | female |
| Hin Lung So | Chief Financial Officer, Company Secretary & Executive Director | 2M | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1830.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
